See Stories from Region:
Filter by Date:
 
  • close  
  • close  
RSS – Research 
News > Medical > Research

Featured

April 2, 2015 - 12:58 PM

LinCor Biosciences Announces Funding for Development of Its Bioengineered Cornea

LinCor Biosciences announces an investment by the Indiana Lions Eye Bank toward the development and…

Read More
April 2, 2015 - 12:40 PM

Replicor Announces Completion of Enrollment in Phase II Trial

Replicor Announces Completion of Enrollment in Phase II Trial

Read More
April 2, 2015 - 11:30 AM

Nodality Launches PathPro™ Chronic Lymphocytic Leukemia (CLL) Panels Based on Leading Single Cell Network Profiling (SCNPTM) Platform to Enhance Pharmaceutical R&D;

Four PathPro Products Currently Available – Including PathPro™ JAK-STAT panel,…

Read More

Latest

April 2, 2015 - 12:58 PM

LinCor Biosciences Announces Funding for Development of Its Bioengineered Cornea

LinCor Biosciences announces an investment by the Indiana Lions Eye Bank toward the development and commercialization of the Company's bioengineered cornea…

Read More
April 2, 2015 - 12:40 PM

Replicor Announces Completion of Enrollment in Phase II Trial

Replicor Announces Completion of Enrollment in Phase II Trial

Read More
April 2, 2015 - 11:30 AM

Nodality Launches PathPro™ Chronic Lymphocytic Leukemia (CLL) Panels Based on Leading Single Cell Network Profiling (SCNPTM) Platform to Enhance Pharmaceutical R&D;

Four PathPro Products Currently Available – Including PathPro™ JAK-STAT panel, PathPro™ TLR, and the PathPro™ AML panels –…

Read More
April 2, 2015 - 06:41 AM

PPD Names Proven Leader for GMP Laboratory Services

Jon Denissen will oversee labs in U.S. and Europe

Read More
April 2, 2015 - 06:30 AM

Augmenix Announces FDA Clearance of SpaceOAR® System

First-of-its-kind Treatment Offers Significant Clinical Benefits to Prostate Cancer Patients Undergoing Radiotherapy

Read More
April 2, 2015 - 05:31 AM

Perosphere Receives FDA Fast Track Designation for Investigational Anticoagulant Reversal Agent PER977

Perosphere Receives FDA Fast Track Designation for Investigational Anticoagulant Reversal Agent PER977

Read More